Lucid Diagnostics Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Lucid Diagnostics Inc. (LUCD) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$276.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-12
- Lucid Diagnostics Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $243.00K, a 30.37% decline year-over-year.
- Lucid Diagnostics Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$519.00K.
- Lucid Diagnostics Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $443.00K, a 46.24% decline year-over-year.
- Lucid Diagnostics Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$146.00K.
- Lucid Diagnostics Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$110.00K.
- Lucid Diagnostics Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$1.01M, a 142.27% decline from fiscal 2023.
- Lucid Diagnostics Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $2.39M, a 618.92% increase from fiscal 2022.
- Lucid Diagnostics Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $333.00K, a 64.04% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$276.00K 10-Q · filed 2026-08-12 | $167.00K derived: sum of 3 quarters · filed 2026-08-12 | $21.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$519.00K 10-Q · filed 2026-05-13 | -$76.00K derived: sum of 2 quarters · filed 2026-05-13 | -$222.00K derived: sum of 3 quarters · filed 2026-05-13 | $127.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $297.00K derived: sum of 2 quarters · filed 2026-03-25 | $646.00K derived: sum of 3 quarters · filed 2026-08-12 | -$110.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | -$146.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $203.00K derived: sum of 2 quarters · filed 2026-08-12 | -$553.00K 10-Q · filed 2025-11-12 | $271.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $349.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$407.00K 10-Q · filed 2026-08-12 | $417.00K derived: sum of 3 quarters · filed 2026-08-12 | -$305.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$756.00K 10-Q · filed 2026-05-13 | $68.00K derived: sum of 2 quarters · filed 2026-05-13 | -$654.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.06M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $824.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $102.00K derived: sum of 2 quarters · filed 2026-03-25 | -$308.00K derived: sum of 3 quarters · filed 2026-03-25 | -$1.01M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$722.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.13M derived: sum of 2 quarters · filed 2025-11-12 | -$1.84M 10-Q · filed 2025-11-12 | -$1.32M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$410.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.11M 10-Q · filed 2025-08-12 | -$598.00K derived: sum of 3 quarters · filed 2025-08-12 | $87.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$704.00K 10-Q · filed 2025-05-13 | -$188.00K derived: sum of 2 quarters · filed 2025-05-13 | $497.00K derived: sum of 3 quarters · filed 2025-05-13 | $947.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $516.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.20M derived: sum of 2 quarters · filed 2025-03-24 | $1.65M derived: sum of 3 quarters · filed 2025-03-24 | $2.39M 10-K · filed 2025-03-24 |
| 2023-09-30 | $685.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.14M derived: sum of 2 quarters · filed 2024-11-12 | $1.88M 10-Q · filed 2024-11-12 | $2.19M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.19M 10-Q · filed 2024-08-12 | $1.51M derived: sum of 3 quarters · filed 2024-08-12 | $1.39M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $743.00K 10-Q · filed 2024-05-13 | $1.06M derived: sum of 2 quarters · filed 2024-05-13 | $944.00K derived: sum of 3 quarters · filed 2024-05-13 | $791.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $201.00K derived: sum of 2 quarters · filed 2024-03-25 | $48.00K derived: sum of 3 quarters · filed 2024-03-25 | $333.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | -$116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$269.00K derived: sum of 2 quarters · filed 2023-11-13 | $16.00K 10-Q · filed 2023-11-13 | $806.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $132.00K 10-Q · filed 2023-08-14 | $922.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.08M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $285.00K 10-Q · filed 2023-05-15 | $1.07M derived: sum of 2 quarters · filed 2023-05-15 | $1.24M derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $790.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $952.00K derived: sum of 2 quarters · filed 2023-03-14 | $926.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $136.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$26.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |